Your browser doesn't support javascript.
loading
Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan.
Masumori, Naoya; Tsukamoto, Taiji; Shibuya, Akihiko; Miyao, Noriomi; Kunishima, Yasuharu; Iwasawa, Akihiko.
Affiliation
  • Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo.
  • Tsukamoto T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo.
  • Shibuya A; Kaguraoka Urological Clinic, Asahikawa.
  • Miyao N; Division of Urology, Muroran City General Hospital, Muroran.
  • Kunishima Y; Hokkaido Social Work Association Obihiro Hospital, Obihiro.
  • Iwasawa A; Iwasawa Clinic, Sapporo, Japan.
Patient Prefer Adherence ; 10: 1309-16, 2016.
Article in En | MEDLINE | ID: mdl-27524886
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Patient Prefer Adherence Year: 2016 Document type: Article Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Patient Prefer Adherence Year: 2016 Document type: Article Country of publication: New Zealand